Susan L. Rosenthal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Susan L. Rosenthal has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
- Marina Catallozzi
Division of Child and Adolescent Health Department of Pediatrics Columbia University Irving Medical Center New York, NY United States
4 shared publications - Christine Mauro
Department of Biostatistics, Columbia University Mailman School of Public Health, New York, USA
3 shared publications - Sara E. Landers
Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, 593 Eddy Street, Providence, RI, 02903, USA.
3 shared publications - Jenny K. R. Francis
Department of Pediatrics, UT Southwestern Medical Center, Dallas, Texas; Children's Health System of Texas, Dallas, Texas; Peter O'Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, Texas
2 shared publications - Lawrence Raymond Stanberry
Vaccine Information Network, Columbia University, 533 W 218th St., New York, NY 10032, USA
2 shared publications A Mindel
University of Sydney School of Medical, Sydney, Australia
1 shared publication
Latest Publications
- Open Access
- 18 July 2024
- Published by Wiley in Journal of the International AIDS Society
- Vol. 27 (S3) , e26320
Mental health and cognition in relation to adherence to antiretroviral therapy among people living with HIV in Kazakhstan: a cross‐sectional study
Introduction: There is a research gap in how mental health and cognition are associated with antiretroviral treatment (ART) adherence among people living with HIV (PLWH) in Kazakhstan.Methods: We randomly selected and enrolled 230 PLWH from the Almaty City AIDS Center registry (June−November 2019) into a cross‐sectional study. We examined associations between self‐reported ART adherence for the last 1 and 2 weeks; the Adherence Self‐Efficacy Scale (ASES) and symptoms of depression (Patient Health Questionnaire‐9 [PHQ‐9]), anxiety (Generalized Anxiety Disorder tool [GAD‐7]), post‐traumatic stress disorder (PTSD Checklist [PTSD]); cognitive function (PROMIS v2.0 Adult Cognitive Function 8a short form) and forgetfulness (Forgetfulness Assessment Inventory). We used cut points of ≥5 for at least mild and ≥10 for at least moderate symptom severity for PHQ‐9 and GAD‐7 and of ≥44 for PTSD. Logistic and linear regression analyses were used.Results: Participants’ median age was 40.0 (IQR: 34−47) with 40.9% (n = 94) of females in the sample. Those who missed at least one pill for the last 2 weeks had higher odds of reporting at least mild depression (aOR = 3.34, 95% CI: 1.22–9.11, p < 0.05); mild anxiety (aOR = 3.27, 95% CI: 1.20–8.92, p < 0.05); and PTSD (aOR = 4.04, 95% CI: 1.15–14.21, p < 0.05) symptoms. Participants who missed at least one pill for the last week had higher odds of at least mild depression (aOR = 7.74, 95% CI: 1.31–45.7, p < 0.05), moderate anxiety (aOR = 21.33, 95% CI: 3.24–140.33, p < 0.005) and PTSD (aOR = 13.81, 95% CI: 2.36–80.84, p < 0.005) symptoms. Participants with better cognitive function had lower odds of non‐adherence over the last week (aOR = 0.88, 95% CI: 0.81–0.96, p < 0.005) and higher ASES scores (β = 0.26, 95% CI: 0.13–0.40, p < 0.005). Poor memory was associated with higher odds of non‐adherence over the last week (aOR = 4.64, 95% CI: 1.76–12.24, p < 0.005) and lower ASES score (β = −0.31, 95% CI: −0.45 to 0.16, p < 0.005). Those who had at least mild depression (β = −0.21, 95% CI: −0.35 to −0.07, p < 0.005); moderate anxiety (β = −0.21, 95% CI: −0.34 to −0.07, p < 0.005) and PTSD (β = −0.19, 95% CI: −0.33 to −0.05, p < 0.005) symptoms had lower ASES scores.Conclusions: Depression, anxiety and PTSD symptoms, poorer cognition, and forgetfulness were associated with poorer ART adherence and worse adherence self‐efficacy. It is crucial to assess and treat mental illness and provide support for PLWH with worsened cognition to enhance ART adherence.
- 18 July 2024
- Published by Wiley in Journal of the International AIDS Society
- Vol. 27 (S3) , e26320
Open AccessMental health and cognition in relation to adherence to antiretroviral therapy among people living with HIV in Kazakhstan: a cross‐sectional study
Introduction: There is a research gap in how mental health and cognition are associated with antiretroviral treatment (ART) adherence among people living with HIV (PLWH) in Kazakhstan.Methods: We randomly selected and enrolled 230 PLWH from the Almaty City AIDS Center registry (June−November 2019) into a cross‐sectional study. We examined associations between self‐reported ART adherence for the last 1 and 2 weeks; the Adherence Self‐Efficacy Scale (ASES) and symptoms of depression (Patient Health Questionnaire‐9 [PHQ‐9]), anxiety (Generalized Anxiety Disorder tool [GAD‐7]), post‐traumatic stress disorder (PTSD Checklist [PTSD]); cognitive function (PROMIS v2.0 Adult Cognitive Function 8a short form) and forgetfulness (Forgetfulness Assessment Inventory). We used cut points of ≥5 for at least mild and ≥10 for at least moderate symptom severity for PHQ‐9 and GAD‐7 and of ≥44 for PTSD. Logistic and linear regression analyses were used.Results: Participants’ median age was 40.0 (IQR: 34−47) with 40.9% (n = 94) of females in the sample. Those who missed at least one pill for the last 2 weeks had higher odds of reporting at least mild depression (aOR = 3.34, 95% CI: 1.22–9.11, p < 0.05); mild anxiety (aOR = 3.27, 95% CI: 1.20–8.92, p < 0.05); and PTSD (aOR = 4.04, 95% CI: 1.15–14.21, p < 0.05) symptoms. Participants who missed at least one pill for the last week had higher odds of at least mild depression (aOR = 7.74, 95% CI: 1.31–45.7, p < 0.05), moderate anxiety (aOR = 21.33, 95% CI: 3.24–140.33, p < 0.005) and PTSD (aOR = 13.81, 95% CI: 2.36–80.84, p < 0.005) symptoms. Participants with better cognitive function had lower odds of non‐adherence over the last week (aOR = 0.88, 95% CI: 0.81–0.96, p < 0.005) and higher ASES scores (β = 0.26, 95% CI: 0.13–0.40, p < 0.005). Poor memory was associated with higher odds of non‐adherence over the last week (aOR = 4.64, 95% CI: 1.76–12.24, p < 0.005) and lower ASES score (β = −0.31, 95% CI: −0.45 to 0.16, p < 0.005). Those who had at least mild depression (β = −0.21, 95% CI: −0.35 to −0.07, p < 0.005); moderate anxiety (β = −0.21, 95% CI: −0.34 to −0.07, p < 0.005) and PTSD (β = −0.19, 95% CI: −0.33 to −0.05, p < 0.005) symptoms had lower ASES scores.Conclusions: Depression, anxiety and PTSD symptoms, poorer cognition, and forgetfulness were associated with poorer ART adherence and worse adherence self‐efficacy. It is crucial to assess and treat mental illness and provide support for PLWH with worsened cognition to enhance ART adherence.
- Open Access
- 1 April 2024
- Published by Elsevier in International Journal of Hygiene and Environmental Health
- Vol. 259, 114357
Infection prevention and control and related practices in African neonatal units: The Pan-African neonatal care assessment study (PANCAS)
- 1 April 2024
- Published by Elsevier in International Journal of Hygiene and Environmental Health
- Vol. 259, 114357
Open AccessInfection prevention and control and related practices in African neonatal units: The Pan-African neonatal care assessment study (PANCAS)
- 10 December 2021
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 69 (3) , e29497
Provider and staff crisis well‐being associated with trust in leadership and baseline burnout
Background: The impact of the coronavirus 2019 (COVID‐19) pandemic on the emotional health of health care workers continues to be an area of active research. However, few studies have focused on those working in pediatrics and its subspecialties, as well as ancillary and non‐patient‐facing staff. The purpose of this study was to determine the prevalence and associated predictors of burnout and emotional well‐being of providers and staff.Methods: An anonymous electronic survey was developed evaluating demographics, pandemic experiences, possible predictor variables, and three main outcomes of burnout, psychological distress, and perceived stress. Pediatric hematology oncology (PHO) chiefs and program directors across the country were invited to participate and disseminate the survey to their programs.Results: A total of 682/1950 (35% of invited) individuals responded to all predictor and outcome variables. Over half reported high levels of burnout and some reported moderate/high levels of distress. Prepandemic burnout and decreased trust in leadership were associated with all three outcomes. Additional predictors included having a child ≤18 years at home, hospital role, and worrying about patient care or relationship with their patients. The majority (n = 444/682, 65.5%) reported that their institution had made COVID‐19‐related mental health resources available. However, only 6.5% (n = 44/682) reported utilizing these resources.Conclusions: While the majority of PHO providers and staff were resilient during the early stages of the COVID‐19 pandemic, many reported high levels of burnout, yet few are utilizing institutional resources. This study has highlighted several actionable areas to help identify and address factors that are wearing down the emotional well‐being of providers and staff.
- 10 December 2021
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 69 (3) , e29497
Provider and staff crisis well‐being associated with trust in leadership and baseline burnout
Background: The impact of the coronavirus 2019 (COVID‐19) pandemic on the emotional health of health care workers continues to be an area of active research. However, few studies have focused on those working in pediatrics and its subspecialties, as well as ancillary and non‐patient‐facing staff. The purpose of this study was to determine the prevalence and associated predictors of burnout and emotional well‐being of providers and staff.Methods: An anonymous electronic survey was developed evaluating demographics, pandemic experiences, possible predictor variables, and three main outcomes of burnout, psychological distress, and perceived stress. Pediatric hematology oncology (PHO) chiefs and program directors across the country were invited to participate and disseminate the survey to their programs.Results: A total of 682/1950 (35% of invited) individuals responded to all predictor and outcome variables. Over half reported high levels of burnout and some reported moderate/high levels of distress. Prepandemic burnout and decreased trust in leadership were associated with all three outcomes. Additional predictors included having a child ≤18 years at home, hospital role, and worrying about patient care or relationship with their patients. The majority (n = 444/682, 65.5%) reported that their institution had made COVID‐19‐related mental health resources available. However, only 6.5% (n = 44/682) reported utilizing these resources.Conclusions: While the majority of PHO providers and staff were resilient during the early stages of the COVID‐19 pandemic, many reported high levels of burnout, yet few are utilizing institutional resources. This study has highlighted several actionable areas to help identify and address factors that are wearing down the emotional well‐being of providers and staff.
- Open Access
- 1 May 2020
- Published by Wiley in Ethics & Human Research
- Vol. 42 (3) , 2-11
Adolescent and Parent Perceptions about Participation in Biomedical Sexual Health Trials
Given the burden of HIV and other sexually transmitted infections among adolescents who are legal minors, it is critical that they be included in biomedical sexual health trials to ensure that new prevention and treatment interventions are safe, effective, and acceptable for their use. However, adolescents are often not well represented in clinical trials. We provide an overview of the available evidence regarding adolescent and parent willingness for adolescents to participate in biomedical sexual health trials, parental involvement in the permission‐consent process, management of differences and discord among adolescents and parents, and parental involvement throughout the study period. We also outline recommendations for current practice and areas for future research.
- 1 May 2020
- Published by Wiley in Ethics & Human Research
- Vol. 42 (3) , 2-11
Open AccessAdolescent and Parent Perceptions about Participation in Biomedical Sexual Health Trials
Given the burden of HIV and other sexually transmitted infections among adolescents who are legal minors, it is critical that they be included in biomedical sexual health trials to ensure that new prevention and treatment interventions are safe, effective, and acceptable for their use. However, adolescents are often not well represented in clinical trials. We provide an overview of the available evidence regarding adolescent and parent willingness for adolescents to participate in biomedical sexual health trials, parental involvement in the permission‐consent process, management of differences and discord among adolescents and parents, and parental involvement throughout the study period. We also outline recommendations for current practice and areas for future research.
- 28 March 2020
- Published by Springer Nature in Journal of Technology in Behavioral Science
- Vol. 5 (3) , 258-265
Acceptability of a Phone App-Based Motivational Interviewing Intervention for Young Men’s Health
- 28 March 2020
- Published by Springer Nature in Journal of Technology in Behavioral Science
- Vol. 5 (3) , 258-265
Acceptability of a Phone App-Based Motivational Interviewing Intervention for Young Men’s Health
- Open Access
- 13 August 2018
- Published by SAGE Publications in Journal of Empirical Research on Human Research Ethics
- Vol. 13 (4) , 383-390
Adolescents’ and Parents’ Attitudes Toward Adolescent Clinical Trial Participation: Changes Over One Year
Little is known about how adolescents’ and parents’ thoughts about participation in clinical trials change over time. In this study, adolescent (14-17 years)–parent dyads were asked about willingness to participate in a hypothetical reproductive health study. A year later, they were asked how their thoughts about the study had changed. Qualitative responses were coded and analyzed using framework analysis. Thirty-two percent of adolescents and 18% of parents reported changes in thoughts; reasons included general changes in perception, clearer understanding, new knowledge or experiences, increased maturity/age of adolescents, and changes in participants independent of the study. Adolescents and parents may benefit from learning about studies multiple times, and investigators should account for development and new experiences to optimize adolescent research enrollment.
- 13 August 2018
- Published by SAGE Publications in Journal of Empirical Research on Human Research Ethics
- Vol. 13 (4) , 383-390
Open AccessAdolescents’ and Parents’ Attitudes Toward Adolescent Clinical Trial Participation: Changes Over One Year
Little is known about how adolescents’ and parents’ thoughts about participation in clinical trials change over time. In this study, adolescent (14-17 years)–parent dyads were asked about willingness to participate in a hypothetical reproductive health study. A year later, they were asked how their thoughts about the study had changed. Qualitative responses were coded and analyzed using framework analysis. Thirty-two percent of adolescents and 18% of parents reported changes in thoughts; reasons included general changes in perception, clearer understanding, new knowledge or experiences, increased maturity/age of adolescents, and changes in participants independent of the study. Adolescents and parents may benefit from learning about studies multiple times, and investigators should account for development and new experiences to optimize adolescent research enrollment.
- 18 May 2017
- Published by CSIRO Publishing in Sexual Health
- Vol. 14 (6) , 581-583
Pregnant young women’s attitudes about microbicides: the anticipated influence of the grandmother and father of the baby on microbicide use
Grandmothers and fathers of the baby may influence pregnant women’s microbicide use. Pregnant young women’s attitudes about grandmothers’ and fathers’ role in decision-making and their involvement in microbicide use were assessed. Participants (n = 108) had a mean age of 20.2 years. The majority anticipated that the grandmother, father or both would have a decision-making role. Greater grandmother involvement in microbicide use was significantly associated with being younger, having no reproductive tract infection or contraceptive-ring-use history. Greater father involvement in use was associated with being in a relationship with him. Strategies for engaging grandmothers and fathers in microbicide use should be developed.
- 18 May 2017
- Published by CSIRO Publishing in Sexual Health
- Vol. 14 (6) , 581-583
Pregnant young women’s attitudes about microbicides: the anticipated influence of the grandmother and father of the baby on microbicide use
Grandmothers and fathers of the baby may influence pregnant women’s microbicide use. Pregnant young women’s attitudes about grandmothers’ and fathers’ role in decision-making and their involvement in microbicide use were assessed. Participants (n = 108) had a mean age of 20.2 years. The majority anticipated that the grandmother, father or both would have a decision-making role. Greater grandmother involvement in microbicide use was significantly associated with being younger, having no reproductive tract infection or contraceptive-ring-use history. Greater father involvement in use was associated with being in a relationship with him. Strategies for engaging grandmothers and fathers in microbicide use should be developed.
- Open Access
- 13 July 2013
- Published by BMJ in Sexually Transmitted Infections
- Vol. 89 (Suppl 1) , A332.3-A333
P4.146 Disclosing Genital Herpes: Perceptions of Motivation, Logistics and Timing
Objective The aim of the study was to evaluate the lay public’s portrayal of disclosure of Herpes simplex virus (HSV) infection. Methods The Australian Herpes Management Forum and Novartis Pharmaceuticals organised an on-line contest in 2011, challenging contestants to develop 30-second videos addressing ‘how you tell a partner you have HSV’ given that ‘for many people shame and stigma are so overwhelming that they don’t feel comfortable talking about it.’ Results Sixty-three videos were analysed for the following thematic content regarding disclosure: motivation, strategies/logistics and timing/context. The portrayed motivations included: no reason not to disclose, given the ease of disease management; to be consistent with values (e.g., respect, honesty); or to avoid the risk of accidental ‘outing’. Other videos only commanded disclosure without providing a rationale. With regards to strategies and logistics, most disclosures occurred in a private or semi-private setting, often of a romantic/intimate nature and in a direct manner. However, some used an indirect/non-verbal approach (e.g., giving a pamphlet or as part of a game). A few showed consideration of the partner’s need for time to respond. A few showed the individual practising disclosure. The timing and context of disclosure varied and was often unclear; however, some videos demonstrated disclosure occurring post-coitally. Conclusions Some video creators viewed disclosure as occurring in romantic settings, post-coitally, and in a non-direct manner, all of which are not consistent with traditional counselling messages. Disclosing in a romantic setting and in non-direct ways may be reasonable; it would still be desirable for disclosure to occur pre-coitally. Understanding these differences may help develop counselling messages that resonate with patient expectations and are more effective in promoting disclosure. Future research should collect patient experiences and perceived outcomes of disclosure in terms of the setting, method, and timing of disclosure.
- 13 July 2013
- Published by BMJ in Sexually Transmitted Infections
- Vol. 89 (Suppl 1) , A332.3-A333
Open AccessP4.146 Disclosing Genital Herpes: Perceptions of Motivation, Logistics and Timing
Objective The aim of the study was to evaluate the lay public’s portrayal of disclosure of Herpes simplex virus (HSV) infection. Methods The Australian Herpes Management Forum and Novartis Pharmaceuticals organised an on-line contest in 2011, challenging contestants to develop 30-second videos addressing ‘how you tell a partner you have HSV’ given that ‘for many people shame and stigma are so overwhelming that they don’t feel comfortable talking about it.’ Results Sixty-three videos were analysed for the following thematic content regarding disclosure: motivation, strategies/logistics and timing/context. The portrayed motivations included: no reason not to disclose, given the ease of disease management; to be consistent with values (e.g., respect, honesty); or to avoid the risk of accidental ‘outing’. Other videos only commanded disclosure without providing a rationale. With regards to strategies and logistics, most disclosures occurred in a private or semi-private setting, often of a romantic/intimate nature and in a direct manner. However, some used an indirect/non-verbal approach (e.g., giving a pamphlet or as part of a game). A few showed consideration of the partner’s need for time to respond. A few showed the individual practising disclosure. The timing and context of disclosure varied and was often unclear; however, some videos demonstrated disclosure occurring post-coitally. Conclusions Some video creators viewed disclosure as occurring in romantic settings, post-coitally, and in a non-direct manner, all of which are not consistent with traditional counselling messages. Disclosing in a romantic setting and in non-direct ways may be reasonable; it would still be desirable for disclosure to occur pre-coitally. Understanding these differences may help develop counselling messages that resonate with patient expectations and are more effective in promoting disclosure. Future research should collect patient experiences and perceived outcomes of disclosure in terms of the setting, method, and timing of disclosure.
- 1 February 2008
- Published by Elsevier in Journal of Adolescent Health
- Vol. 42 (2) , 28-29
32: Vaccine-Type HPV Infection and Post-Licensure Attitudes About HPV Vaccination in Young Women
- 1 February 2008
- Published by Elsevier in Journal of Adolescent Health
- Vol. 42 (2) , 28-29
32: Vaccine-Type HPV Infection and Post-Licensure Attitudes About HPV Vaccination in Young Women
- Open Access
- 1 April 2001
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 12 (4) , 279-280
Young men's views about topical microbicides
- 1 April 2001
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 12 (4) , 279-280
Open AccessYoung men's views about topical microbicides